Strategic angle: New research reveals how political beliefs influence responses to health crises and the effectiveness of normative messaging.
Strategic angle: A new microscopy technique developed by Helmholtz Munich and TUM distinguishes lipid species in living cells without dyes.
Strategic angle: Decision clears path for April closing after months of scrutiny over keeping key space technology in domestic hands.
Strategic angle: New research is significantly revising a widely cited evolutionary model, the Inhibitory Cascade Model (ICM).
Strategic angle: Scientists uncover new mechanisms promoting cell-cell adhesion, impacting skin and inflammatory diseases.
Strategic angle: A breakthrough in laser technology could revolutionize scientific discovery and practical applications.
Strategic angle: Silicon's compatibility with existing chip technology enhances its role in quantum computing.
Strategic angle: Using AI to analyze changes in brain scans can predict Alzheimer’s with nearly 93 percent accuracy, scientists say.
Strategic angle: A JAMA study details how lead lingers in the body and how it can elevate blood pressure, harm blood vessel lining, and raise risk of heart attack.
Strategic angle: Four astronauts from the United States and Canada are about to take off on the Artemis II mission that will circle the Moon.
Strategic angle: NASA's Apollo moonshots are a tough act to follow, even after all this time.
The four Artemis 2 astronauts arrived in Florida for final preparations ahead of their upcoming launch.
Strategic angle: This Women’s History Month, we look at how women’s innovations have advanced the field of computer programming.
Strategic angle: A new study reveals that remote work may contribute to increased fertility rates among couples.
Strategic angle: American Rare Earths Ltd is advancing its efforts in the heavy rare earths sector with a new study.
Strategic angle: New research reveals the mechanism by which graphene selectively eliminates bacteria, crucial for hygiene in everyday items.
Strategic angle: Rocket Pharmaceuticals sees a significant commercial advantage following the FDA's approval of KRESLADI.
Strategic angle: CERN scientists successfully transport antiprotons, paving the way for future antimatter delivery systems.
Strategic angle: Yeast cells demonstrate a unique method for selecting mates, potentially offering insights into partner selection.
Strategic angle: Rocket Lab Corporation has announced a significant contract with the Department of Defense, marking a major milestone for the company.